These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28439104)

  • 21. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
    Pilar-Cuéllar F; Vidal R; Pazos A
    Br J Pharmacol; 2012 Feb; 165(4b):1046-57. PubMed ID: 21627639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the amygdala in antidepressant effects on hippocampal cell proliferation and survival and on depression-like behavior in the rat.
    Castro JE; Varea E; Márquez C; Cordero MI; Poirier G; Sandi C
    PLoS One; 2010 Jan; 5(1):e8618. PubMed ID: 20062812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p75 neurotrophin receptor regulates basal and fluoxetine-stimulated hippocampal neurogenesis.
    Colditz MJ; Catts VS; Al-menhali N; Osborne GW; Bartlett PF; Coulson EJ
    Exp Brain Res; 2010 Jan; 200(2):161-7. PubMed ID: 19621217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase Mζ is involved in the modulatory effect of fluoxetine on hippocampal neurogenesis in vitro.
    Wang YX; Zhang XR; Zhang ZJ; Li L; Xi GJ; Wu D; Wang YJ
    Int J Neuropsychopharmacol; 2014 Sep; 17(9):1429-41. PubMed ID: 24679950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac).
    Svenningsson P; Tzavara ET; Witkin JM; Fienberg AA; Nomikos GG; Greengard P
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3182-7. PubMed ID: 11880651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple serotonergic paths to antidepressant efficacy.
    Lutz PE
    J Neurophysiol; 2013 May; 109(9):2245-9. PubMed ID: 23343901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of a short-term high-fat diet in an animal model of depression in rats treated with the 5-HT3 receptor antagonist, ondansetron, the 5-HT3 receptor agonist, 2-methyl-5-HT, and the SSRI, fluoxetine.
    Sumaya IC; Bailey D; Catlett SL
    Pharmacol Biochem Behav; 2016 May; 144():78-84. PubMed ID: 26979154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities.
    Quesseveur G; David DJ; Gaillard MC; Pla P; Wu MV; Nguyen HT; Nicolas V; Auregan G; David I; Dranovsky A; Hantraye P; Hen R; Gardier AM; Déglon N; Guiard BP
    Transl Psychiatry; 2013 Apr; 3(4):e253. PubMed ID: 23632457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal fluoxetine exposure induces life-long serotonin 5-HT₃ receptor-dependent cortical abnormalities and anxiety-like behaviour.
    Smit-Rigter LA; Noorlander CW; von Oerthel L; Chameau P; Smidt MP; van Hooft JA
    Neuropharmacology; 2012 Feb; 62(2):865-70. PubMed ID: 21964434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Mechanisms of Exercise-induced Hippocampal Neurogenesis and Antidepressant Effects.
    Kondo M
    JMA J; 2023 Apr; 6(2):114-119. PubMed ID: 37179732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent decline in hippocampal neurogenesis is not altered by chronic treatment with fluoxetine.
    Cowen DS; Takase LF; Fornal CA; Jacobs BL
    Brain Res; 2008 Sep; 1228():14-9. PubMed ID: 18616933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium counteracts depressive behavior and augments the treatment effect of selective serotonin reuptake inhibitor in treatment-resistant depressed rats.
    Kin K; Yasuhara T; Kawauchi S; Kameda M; Hosomoto K; Tomita Y; Umakoshi M; Kuwahara K; Kin I; Kidani N; Morimoto J; Sasaki T; Date I
    Brain Res; 2019 Aug; 1717():52-59. PubMed ID: 30953607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice.
    Egeland M; Warner-Schmidt J; Greengard P; Svenningsson P
    Biol Psychiatry; 2010 Jun; 67(11):1048-56. PubMed ID: 20227680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues.
    Kim EJ; Felsovalyi K; Young LM; Shmelkov SV; Grunebaum MF; Cardozo T
    Psychopharmacology (Berl); 2018 Sep; 235(9):2643-2650. PubMed ID: 29961917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine increased adult neurogenesis is mediated by 5-HT3 receptor.
    Olivas-Cano I; Rodriguez-Andreu JM; Blasco-Ibañez JM; Crespo C; Nácher J; Varea E
    Neurosci Lett; 2023 Jan; 795():137027. PubMed ID: 36566831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord.
    Engesser-Cesar C; Anderson AJ; Cotman CW
    Neuroscience; 2007 Feb; 144(3):1033-44. PubMed ID: 17137724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activating newborn neurons suppresses depression and anxiety-like behaviors.
    Tunc-Ozcan E; Peng CY; Zhu Y; Dunlop SR; Contractor A; Kessler JA
    Nat Commun; 2019 Aug; 10(1):3768. PubMed ID: 31434877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice.
    Lesemann A; Reinel C; Hühnchen P; Pilhatsch M; Hellweg R; Klaissle P; Winter C; Steiner B
    Brain Res; 2012 May; 1457():51-69. PubMed ID: 22520437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.
    Bianchi P; Ciani E; Guidi S; Trazzi S; Felice D; Grossi G; Fernandez M; Giuliani A; Calzà L; Bartesaghi R
    J Neurosci; 2010 Jun; 30(26):8769-79. PubMed ID: 20592198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization.
    Greene J; Banasr M; Lee B; Warner-Schmidt J; Duman RS
    Neuropsychopharmacology; 2009 Oct; 34(11):2459-68. PubMed ID: 19553916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.